Investor Presentaiton

Better than industry growth On Consolidated Basis Revenue (In Rs. Crs.) +18% 998 856 760 644 Bolstering Growth in Wellness Segment METROPOLIS The Pathology Specialist 1,229 Metropolis Wellness revenue contribution for Metropolis is 7% in FY22 FY18 FY19 FY20 FY21 FY22 Revenue growth for B2C (In Rs. Crs.) 546 +19% 429 376 329 273 FY18 FY19 FY20 FY21 FY22 This market is expected to grow at a CAGR of 20% over next 3 financial years (Frost & Sullivan) Customers today are serious about wellness and choose to undergo preventive screening to safeguard their health and diagnose conditions before they turn in to complications This segment is termed as wellness as opposed to the illness wherein the patient has to undergo tests when they are prescribed tests during sickness Wellness & Preventive Diagnostics market is 7% to 9% in FY2018 (Frost & Sullivan) 58

View entire presentation